IMMUNOTHERAPY VERSUS CHEMOTHERAPY IN ADVANCED NON-SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS OF SURVIVAL OUTCOMES AND ADVERSE EVENTS. FMHR [Internet]. 2026 May 26 [cited 2026 Jul. 13];4(5):871-86. Available from: https://fmhr.net/index.php/fmhr/article/view/2945